I built this app on the side for fun. It just hit $100K

Starter Story • • 13min → 2 min • #201
I built this app on the side for fun. It just hit $100K
Watch on YouTube

Summary

  • Chris Chase, a software engineer with 25 years of experience and a fractional CTO, built Peptide IQ as his first solo app and grew it to $14,000 MRR and $115,000+ annual revenue in nine months while working full-time.

Chris’s background and path to Peptide IQ

  • Started programming in the MySpace era, building an app that generated ~$40,000/month as a high school student.
  • Now serves as a fractional CTO leading overseas engineering teams across web, mobile, QA, IT, and DevOps.
  • Peptide IQ was his first venture building an app for himself rather than for clients.

Peptide IQ product and business metrics

  • A tracker for all things peptides with a hard paywall: $30/month or $130/year.
  • As of recording: ~1,400 active subscriptions, $22,000 revenue over 28 days, ~$15,000 MRR, 70 active trials.
  • Target users are primarily 45–55 years old, a demographic less likely to rely solely on AI chat interfaces.

Market validation and differentiation in a saturated category

  • Did not invent a new category; entered a space with dozens of existing GLP-1 and peptide apps.
  • Validated demand by observing the success of GLP-1–focused apps (used for weight loss) and seeing hockey-stick growth in Google search trends for peptides.
  • Differentiated by researching competitor reviews, Reddit discussions, and user complaints to find gaps — then building features that addressed those unmet needs.
  • Believes incumbents move slowly; a solo founder can differentiate and ship faster.

Technical implementation and build timeline

  • Built the MVP in about one week using “vibe coding” (AI-assisted development).
  • Tech stack: Expo + React Native (TypeScript), Supabase (database, auth, payments), RevenueCat (subscriptions), Vercel (marketing site), PostHog (analytics), Sentry (crash reporting).

Growth strategy: SEO and content marketing as the primary engine

  • Invested early in a marketing website structured for SEO, knowing “the best time to plant SEO seeds is yesterday.”
  • SEO took 6–7 months to pay off; now drives ~70% of clicks and revenue at near-zero marginal cost.
  • Over 12 months, blog articles generated 590,000 clicks from Google search.
  • Argues SEO is not dead — it works when the target audience (here, 45–55-year-olds) still uses Google rather than AI-first tools.
  • Also submits sitemap to Bing (partnered with OpenAI) for additional indexing at no cost.

Content creation tactics and tooling

  • Sources article topics from recurring questions on Reddit and other communities where the target audience discusses peptides daily.
  • Produces content via three channels: writing himself, using AI for a majority of articles, and hiring freelance writers.
  • Embeds functional tools directly into articles (e.g., a peptide reconstitution calculator) that capture leads by prompting users to save data into the app after creating an account.
  • Technical SEO basics: proper schema markup, semantic HTML, fast load times, no broken links.
  • Uses SEMrush and Ahrefs to audit own site and reverse-engineer competitors’ top-performing pages and keywords.

App features and AI integration

  • Core features: dosing schedule with upcoming/last dose views, community section, blood-work logging, journaling, drug-interaction checker, educational guides (reconstitution, protocols).
  • AI assistant is not a generic ChatGPT wrapper; it ingests the user’s contextual data — protocol, dosing frequency, missed doses, Apple Health metrics, blood work — to answer personalized questions like “how can I improve my current protocol?”

Advice for founders starting today

  • Build something you’re genuinely passionate about; it won’t feel like work and you’ll move faster than incumbents.
  • Identify where you can differentiate in an existing market and execute quickly — large competitors are often slow to adapt.
  • Start SEO and content early; the compounding returns arrive later but become a durable, low-cost acquisition channel.
Back to Starter Story